The impact of semaglutide on liver fat assessed by serial cardiac CT scans in patients with type 2 diabetes: Results from STOP trial.

RPEP-111402025Golub, Ilana S; Manubolu, Venkat S; Aldana-Bitar, Jairo; Dahal, Suraj; Verghese, Dhiran; Alalawi, Luay; Krishnan, Srikanth; Kianoush, Sina; Benzing, Travis; Ichikawa, Keishi; Kinninger, April; Fazlalizadeh, Hooman; Pourafkari, Leili; Ahmad, Khadije; Susarla, Shriraj; Mangaoang, Czarina; Ghanem, Ahmed K; Javier, Denise Alison; Hamal, Sajad; Roy, Sion K; Budoff, Matthew J

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

The impact of semaglutide on liver fat assessed by serial cardiac CT scans in patients with type 2 diabetes: Results from STOP trial.

Nutrition, metabolism, and cardiovascular diseases : NMCD, 35(9), 104036

View on PubMed ↗Publisher’s paper ↗

Citation

Golub, Ilana S; Manubolu, Venkat S; Aldana-Bitar, Jairo; Dahal, Suraj; Verghese, Dhiran; Alalawi, Luay; Krishnan, Srikanth; Kianoush, Sina; Benzing, Travis; Ichikawa, Keishi; Kinninger, April; Fazlalizadeh, Hooman; Pourafkari, Leili; Ahmad, Khadije; Susarla, Shriraj; Mangaoang, Czarina; Ghanem, Ahmed K; Javier, Denise Alison; Hamal, Sajad; Roy, Sion K; Budoff, Matthew J. (2025). The impact of semaglutide on liver fat assessed by serial cardiac CT scans in patients with type 2 diabetes: Results from STOP trial.. Nutrition, metabolism, and cardiovascular diseases : NMCD, 35(9), 104036. https://doi.org/10.1016/j.numecd.2025.104036